Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo

Abstract

Delivery of therapeutic proteins to patients may be costly to administer, and often requires repeated injections. Here, the authors use antigen-specific T cells expressing erythropoietin, and show that following transfer in mice, cell expansion and erythropoietin production can be boosted by vaccination, raising the haematocrit.